COVID-19 worse for vapers; Experimental drug targets COVID-19 from two angles

1/15/2022 2:50:00 AM

COVID-19 SCIENCE UPDATES COVID-19 worse for vapers; Experimental drug targets COVID-19 from two angles

Zapnometinib, Atr-002

COVID-19 SCIENCE UPDATES COVID-19 worse for vapers; Experimental drug targets COVID-19 from two angles

E-cigarette users infected with the coronavirus may be more likely than infected non-vapers to experience COVID-19 symptoms, according to research published in the Journal of Primary Care & Community Health.An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions, researchers said.

PublishedJanuary 15, 2022 5:54am"Our research was not designed to test whether e-cigarette use increases the risk of acquiring COVID infection, but it clearly indicates that symptom burden in patients with COVID-19 who vape is greater than in those who do not vape," study co-author Dr. Robert Vassallo of the Mayo Clinic in Rochester, Minnesota, said in a news release.

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.Vapers risk more symptoms from COVID-19E-cigarette users infected with the coronavirus may be more likely than infected non-vapers to experience COVID-19 symptoms, according to research published in the

Read more: GMA News »

Free COVID-19 tests, not coercion, best strategy vs COVID-19 surge - PacquiaoPROMDI Party standard bearer Sen. Manny Pacquiao gave this view as he dared government to give free rapid antigen or RT-PCR tests for everybody to protect people from being infected with the dreaded COVID-19 . READ:

#WalangPasok trends on Twitter as schools suspend classes, work amid COVID-19 surgeThe continued increase in COVID-19 infections prompted several universities and colleges to announce the suspension of classes and on-site work among their students and employees.

COVID-19 patients isolating at home now covered by PhilHealth packagePhilHealth says the isolation package will be an option for patients who 'meet the social and clinical criteria' for home quarantine and are able to receive health support directly from their houses. But DOH says don't test mild cases unless A1-3, so how to avail of this?

Malabon City opens pre-registration for 2nd COVID-19 vaccine dose and booster shotThe local government of Malabon said individuals who received their first dose of COVID-19 vaccine outside the city can pre-register to get their second dose in its vaccination sites.

FDA: Pfizer expresses intent to apply for EUA for COVID-19 pill PaxlovidUS Pharmaceutical company Pfizer has expressed intention to apply for an emergency use authorization for its COVID-19 pill Paxlovid, the Philippine Food and Drug Administration said. Josef Mengele likes this tweet.

French teachers strike over chaotic COVID-19 strategy for schools - BusinessWorld OnlinePARIS — French teachers walked off the job on Thursday over what they say is the government’s failure to adopt a coherent policy for schools to manage the COVID-19 pandemic and properly protect pupils and staff against infection.

By NANCY LAPID, Reuters Published January 15, 2022 5:54am "Our research was not designed to test whether e-cigarette use increases the risk of acquiring COVID infection, but it clearly indicates that symptom burden in patients with COVID-19 who vape is greater than in those who do not vape," study co-author Dr.Ben Rosario Arm twisting in order to force citizens to get vaccinated may not be the best strategy in pursuing this objective but providing free and accessible tests for everybody is.Merlina Hernando-Malipot The continued increase in coronavirus disease (COVID-19) infections prompted several universities and colleges to announce the suspension of classes and on-site work among their students and employees.COVID-19 patients who are mild and asymptomatic, and isolating at home are now covered by a Philippine Health Insurance Corporation (PhilHealth) benefit package.

Robert Vassallo of the Mayo Clinic in Rochester, Minnesota, said in a news release. The following is a summary of some recent studies on COVID-19. Manny Pacquiao gave this view as he dared government to give free rapid antigen or RT-PCR tests for everybody to protect people from being infected with the dreaded COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Following the announcement of Manila Mayor Francisco “Isko Moreno” Domagoso that classes in all levels will be suspended in the city from Jan. Vapers risk more symptoms from COVID-19 E-cigarette users infected with the coronavirus may be more likely than infected non-vapers to experience COVID-19 symptoms, according to research published in the Journal of Primary Care & Community Health . Pacquiao is among the political leaders who thumbed down the ‘no vaxx, no ride’ policy of the Department of Transportation. The researchers compared 289 vapers with 1,445 people of similar age and gender who neither vaped nor smoked tobacco, all of whom had tested positive for the coronavirus on PCR tests. Patients covered by CHIBP should also be living in areas identified as high-risk.

Compared to infected non-vapers and after accounting for participants' other risk factors, infected vapers experienced higher rates of chest pain or tightness (16% versus 10%), chills (25% versus 19%), body aches (39% versus 32%), headaches (49% versus 41%), problems with smell and taste (37% versus 30%), nausea/vomiting/abdominal pain (16% versus 10%), diarrhea (16% versus 10%) and light-headedness (16% versus 9%). He said mass testing and systematic contact tracing would allow health authorities to properly segregate and isolate those who are sick without the need to curtail the basic rights of those who are unvaccinated. 10 to 16, all classes including face-to-face, asynchronous, synchronous, and on-site work at will be suspended due to rising COVID-19 infections in the country and among the PLM community. "Our research was not designed to test whether e-cigarette use increases the risk of acquiring COVID infection, but it clearly indicates that symptom burden in patients with COVID-19 who vape is greater than in those who do not vape," study co-author Dr. Robert Vassallo of the Mayo Clinic in Rochester, Minnesota, said in a news release. Pacquiao said that antigen testing facilities should be established in every barangay, in health centers, in malls, and even in workplaces. The inflammation caused by the coronavirus and the inflammation induced by vaping may combine to worsen the likelihood of inflammation throughout the body, with a resulting increase in symptoms, Vassallo and his colleagues suggested. Advisory from PWU PWU said that students shall be allowed to submit asynchronous requirements after Jan. Experimental drug targets COVID-19 from two angles An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions, researchers said.. “Patients shall shoulder payment for services not included in the package,” PhilHealth added.

The drug, called zapnometinib or ATR-002, could potentially curb the proliferation of the virus in cells and also reduce the exaggerated immune response that contributes to critical illness in severe cases of COVID-19, test tube experiments indicated. The data, published on Thursday in the journal Cellular and Molecular Life Sciences , provided the basis on which the German Institute of Drugs and Medicinal Products gave manufacturer Atriva Therapeutics its approval for the drug to be tested in people. “Let us continue to stay safe, observe the public health protocols, get vaccinated and boosted when eligible, and pray for healing and an end to this pandemic,” PWU President Marco Alfredo Benitez said. This marks the first time any drug has been shown to have a dual action against COVID-19, study co-author Stephan Ludwig of the University of Muenster said in a news release. "Positive results from the still-ongoing clinical study in humans might already lead to an emergency approval this year," Ludwig said.  -- Reuters . 24. – Rappler.